Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer

Xin Liu, Emily K.Y. Lam, Xian Wang, Jianbin Zhang, Yuen Yee Cheng, Yun W. Lam, Enders K.O. Ng, Jun Yu, Francis K.L. Chan, Hongchuan Jin, Joseph J.Y. Sung

    Research output: Journal Publications and ReviewsRGC 21 - Publication in refereed journalpeer-review

    29 Citations (Scopus)

    Abstract

    As an important way to inactivate tumor suppressor genes (TSGs) during cancer development, promoter hypermethylation can be used to define novel TSGs and identify biomarkers for cancer diagnosis. SLC19A3 (solute carrier family 19, member 3) was found to be such a biomarker. SLC19A3 expression was downregulated in gastric cancer cell lines (71%, 5/7) and restored after pharmacological demethylation. Notably, hypermethylation of SLC19A3 promoter was detected in gastric cancer cell lines (57%, 4/7), primary gastric carcinoma tissues (51%, 52/101) and precancerous lesion (intestinal metaplasia) tissues (32%, 8/25). Exogenous SLC19A3 expression caused growth inhibition of gastric cancer cells. In summary, SLC19A3 was epigenetically downregulated in gastric cancer. Methylation of SLC19A3 promoter could be a novel biomarker for early gastric cancer development. © 2009 S. Karger AG, Basel.
    Original languageEnglish
    Pages (from-to)242-248
    JournalTumor Biology
    Volume30
    Issue number5-6
    DOIs
    Publication statusPublished - Dec 2009

    Research Keywords

    • Gastric cancer
    • Methylation
    • SLC19A3

    Fingerprint

    Dive into the research topics of 'Promoter hypermethylation mediates downregulation of thiamine receptor SLC19A3 in gastric cancer'. Together they form a unique fingerprint.

    Cite this